Which commercial adjuvants achieve systemic delivery of antimicrobials?

Which commercial adjuvants achieve systemic delivery of antimicrobials?

Report Date: 09/10/2021
Project: 19-023   Year: 2021
Category: CLas Bacteria
Author: Christopher Vincent
Sponsor: Citrus Research and Development Foundation

We have completed this project, having added to it an additional experiment to confirm results and assessment of ‘Ca. L. asiaticus’ bacterial titers in all studies.   In summary we find: · Both originally proposed studies were completed, as well as an additional confirmatory study with both oxytetracycline and streptomycin.· No foliar application treatment achieved a significant systemic delivery or oxytetracycline or streptomycin, nor did any reduce ‘Ca. L. asiaticus’ titer.  · Injection of oxytetracycline exceeded the minimum effective concentration (MEC) and was greater than all adjuvants, and reduced ‘Ca. L. asiaticus’ titer.· Injection of streptomycin at the equivalent per-tree rate to labeled foliar application rates did not exceed MEC, nor did it affect ‘Ca. L. asiaticus’ titer.· Results indicate that:   o Adjuvants to not enhance delivery of oxytetracycline or streptomycin sufficiently to impact ‘Ca. L. asiaticus’ titer at labeled rates.   o Once delivered inside the plant, insufficient streptomycin moves systemically to impact ‘Ca. L. asiaticus’ titer at the equivalent per tree dose to the labeled per-acre equivalent.  PublicationKilliny, N., Hijaz, F., Gonzalez-Blanco, P., Jones, S. E., Pierre, M. O., & Vincent, C. I. (2020). Effect of Adjuvants on Oxytetracycline Uptake upon Foliar Application in Citrus. Antibiotics, 9(10), 677. One additional manuscript presenting the findings of studies 2 and 3 is in preparation. A full report is submitted in a separate pdf.  


Your browser does not support pdfs, click here to download the file.